Titan Company's strong Q2 sales growth and margin guidance update lead to a lower EPS estimate and target price.

Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance after beating third-quarter profit forecasts, boosted by strong sales of copycat medicines and its branded drugs to treat ...

Celsius was breakeven on earnings per share versus the expected $0.02, highlighting financial struggles. Q3 2024 revenue ...

TORONTO — Cineplex Inc. reported a loss in its latest quarter compared with a profit a year ago as it was hit by a fine for ...

Plenty of stock have ridden the boom in artificial intelligence (AI) this year. I'm going to focus on the two that make my ...